AbbVie Inc. ABBV, +4.35% shares rose nearly 3% in premarket trade Thursday after the company reported first-quarter profit and revenue beats and announced plans to buy back up to $7.5 billion in shares.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,